Fulgent Genetics, Inc. (FLGT): Total Liabilities
$106.81M
As of 2025-12-31
$93.24M
As of 2026-06-30
-2.8%
3-year compound annual growth
-4.0%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $106.81M | +17.6% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $90.81M | -11.0% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $102.04M | -12.2% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $116.18M | +3.0% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $112.84M | -13.9% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $131.07M | n/m | 2022-02-28, Balance as of period end |
| 2019-12-31 | $5.98M | +117.3% | 2021-03-08, Balance as of period end |
| 2018-12-31 | $2.75M | -8.4% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $3.01M | -15.6% | 2019-03-22, Balance as of period end |
| 2016-12-31 | $3.56M | +419.1% | 2018-03-20, Balance as of period end |
| 2015-12-31 | $686.0K | n/a | 2017-03-17, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗